Pharmacokinetic/Pharmacodynamic Modeling of GLP-1 in Healthy Rats

By Cao Yanguang   Gao Wei   Jusko William  

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1078-1086

Springer Publishing Company

Access to resources Recommend Favorite

Effects of a Cannabinoid Receptor 2 Selective Antagonist on the Inflammatory Reaction to Titanium Particles In Vivo and In Vitro

By Zhou F   Lu J   Zhu X   Mao H   Yang H   Geng D   Xu Y  

The Journal of International Medical Research, Vol. 38, Iss. 6, 2010-11 ,pp. : 2023-2032

Field House Publishing

Access to resources Recommend Favorite

Integration of in silico and in vitro platforms for pharmacokinetic–pharmacodynamic modeling

By Sung Jong Hwan   Esch Mandy B   Shuler Michael L  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1063-1081

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study

By Höcht Christian   Di Verniero Carla   Opezzo Javier   Bramuglia Guillermo   Taira Carlos  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 4, 2006-07 ,pp. : 310-318

Springer Publishing Company

Access to resources Recommend Favorite

Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents – minimum inhibitory concentration versus time-kill curves

By Schmidt Stephan   Schuck Edgar   Kumar Vipul   Burkhardt Olaf   Derendorf Hartmut  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 849-860

Informa Healthcare

Access to resources Recommend Favorite